Related Articles

Briefing – Mental health and the pandemic – 09-07-2021

While the pandemic is primarily a physical health crisis, it has also had widespread impact on people’s mental health, inducing, among other things, considerable levels of fear, worry, and concern. The growing burden on mental health has been referred to by some as the ‘second’ or ‘silent’ pandemic. While negative mental health consequences affect all ages, young people, in particular, have been found to be at high risk of developing poor mental health. Specific groups have been particularly hard hit, including health and care workers, people with pre-existing mental health problems, and women. The pandemic has also appeared to increase inequalities in mental health, both within the population and between social groups. To address the population’s increased psycho-social needs, the World Health Organization Regional Office for Europe established an expert group on the mental health impacts of Covid-19 in the European region. The Organisation for Economic Co-operation and Development has issued analyses and guidance on mental health in general and the pandemic’s impact on mental health in particular. At European Union level, a December 2020 European Commission communication addressed the pandemic’s impact on mental health. In May 2021, the Commission organised a major online stakeholder event, and published best practice examples of solutions presented. A July 2020 European Parliament resolution recognises mental health as a fundamental human right, calling for a 2021-2027 EU action plan on mental health. Members of the European Parliament have also called on the Commission to put mental health at the heart of EU policymaking. Stakeholders broadly rally around calls for programmes and funding to improve citizens’ mental health, not least to respond to the pandemic’s long-term implications.

Source : © European Union, 2021 – EP

At a Glance – European Medicines Agency mandate extension – 01-07-2021

On 11 November 2020, the European Commission adopted a proposal to strengthen the European Medicines Agency (EMA). The proposed regulation would allow the EMA, among other things, to better anticipate possible shortages of medicinal products and ensure their timely development, with the aim of improving the EU’s capacity to respond to health emergencies. The European Parliament’s Committee on the Environment, Public Health and Food Safety adopted its report on 22 June 2021. This is due to be voted during the July plenary session, thus setting Parliament’s negotiating position and opening the way for interinstitutional negotiations.

Source : © European Union, 2021 – EP

Responses

Your email address will not be published. Required fields are marked *